Gross Margin
28.15%vs Specialty Chemicals peers Updated Aug 21, 2026Profit Margin
-9.83%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Margin
4.84%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Assets (TTM)
-3.50%vs Specialty Chemicals peers Updated Aug 21, 2026Return on Equity (TTM)
-8.60%vs Specialty Chemicals peers Updated Aug 21, 2026Revenue (TTM)
490.10MCNY72.88M · vs all stocks (USD) Updated Aug 21, 2026Revenue per Share (TTM)
5.04CNYUpdated Aug 21, 2026Quarterly Revenue Growth
25.70%vs Specialty Chemicals peers Updated Aug 21, 2026Gross Profit (TTM)
135.91MCNY20.21M · vs all stocks (USD) Updated Aug 21, 2026EBITDA (TTM)
149.94KCNY22.30K · vs all stocks (USD) Updated Aug 21, 2026Net Income (TTM)
-48.15MCNY-7.16M · vs all stocks (USD) Updated Aug 21, 2026Quarterly Earnings Growth (YoY)
3.00%vs Specialty Chemicals peers Updated Aug 21, 2026Operating Cash Flow (TTM)
-26.23MCNY-3.90M · vs all stocks (USD) Updated Aug 21, 2026Levered Free Cash Flow (TTM)
1.89MCNY280.67K · vs all stocks (USD) Updated Aug 21, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 21, 2026Minority Interest (Equity)
112.58MCNYFY2025 · Dec 31, 2025Revenue
457.85MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
292.03MCNYFY2025 · Dec 31, 2025Gross Profit
165.82MCNYFY2025 · Dec 31, 2025Operating Income
-36.57MCNY-5.44M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-79.08MCNYFY2025 · Dec 31, 2025Income Tax Expense
-18.54MCNYFY2025 · Dec 31, 2025Net Income
-60.54MCNYFY2025 · Dec 31, 2025EBIT
-67.60MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
149.94KCNYFY2025 · Dec 31, 2025Research & Development
67.19MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
38.45MCNYFY2025 · Dec 31, 2025Other Operating Expenses
4.27MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
166.98KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
11.49MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.5000CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.5000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
96.63MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
96.63MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-60.54MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
12.23MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-130.86MCNYFY2025 · Dec 31, 2025Free Cash Flow
-142.05MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
41.06MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-60.54MCNYFY2025 · Dec 31, 2025Other Non-cash Items
12.05MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
8.78MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-91.14MCNYFY2025 · Dec 31, 2025Capital Expenditures
-11.20MCNYFY2025 · Dec 31, 2025Net Acquisitions
-27.58MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.94MCNYFY2025 · Dec 31, 2025Sale of Investments
143.54KCNYFY2025 · Dec 31, 2025Other Investing Activity
-25.20MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-66.76MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
272.78MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-336.67MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-9.80MCNYFY2025 · Dec 31, 2025Other Financing Charges
107.11MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
33.42MCNYFY2025 · Dec 31, 2025